Dublin, Jan. 19, 2018 -- The "Expected High Growth Market Segments in Molecular Diagnostic Testing" report has been added to ResearchAndMarkets.com's offering.
Molecular testing provides fast and accurate results and the prescence of molecular tests has disrupted several testing markets over the past decade and a half. However, some segments have thrived and others are seeing mature growth levels.
This report details the highest revenue growth areas of molecular testing, as considered by manufacturers of IVD instruments, reagents and supplies. The report covers both high-growth product segments and regional markets of significance.
Expected High Growth Market Segments in Molecular Diagnostic Testing Provides:
- High-Growth Areas in Molecular Infectious Disease Testing
- High-Growth Areas in Molecular Cancer Testing
- High-Growth Areas in Other Molecular Testing
- High-Growth Regions
- Overview of Molecular Test Technologies.
- Top Companies in High-Growth Molecular Testing Markets
- Conclusions and Projections to 2021
Clinical molecular diagnostics refer to in vitro diagnostic (IVD) tests used in patient health care that detect, quantify or characterize nucleic acid analytes, whether pathogenic nucleic acid, patient DNA or patient RNA. As an IVD market, molecular diagnostics refer to the relevant test kits, other reagents and instruments that are used for clinical testing in settings that include reference laboratories, independent labs, hospital labs, other centralized clinical labs and near-patient testing sites such as clinics and physician offices.
The report also covers Inherited disease diagnostics - diagnosis of rare genetic diseases andother inherited traits including pharmacodiagnostic (pharmacokinetic) traits;major area of application is thrombophilia markers and anticoagulant response markers.
Coverage in this report includes:
- Infectious disease diagnostics such as molecular microbiology and virology, including the detection, identification, quantification and nucleic-acid based resistance or susceptibility profiling of pathogens
- Blood Transfusion Diagnostics, nucleic acid screening (NAT) of donated blood, often pooled samples, for the detection of active infections responsible for transfusion transmitted infections (TTIs)
- ancillary market for molecular immunohematology or blood typing
- Histology / cytology diagnostics , which is largely synonymous with in situ hybridization (ISH) methods that use direct hybridization of chromogenic (CISH) or fluorescent (FISH) nucleic acid probes within slided tissue or suspended cell samples viewed under microscopy;Molecular Cancer Diagnostics, which are tissue, blood and urine samples can be assayed using nucleic acid amplification tests (NAATs) or sequencing to diagnose, prognose and identify key mutations for targeted therapies
- future
- Transplant diagnostics - various PCR-based methodologies, Sanger sequencing and NGS used to type HLA alleles in low to high resolution in order to match donors and recipients for solid organ and hematopoietic stem cell (HSCT) or bone marrow transplants, as well as post-transplant monitoring.
Key Topics Covered:
1: Executive Summary
Introduction
Molecular Diagnostic Technologies
Molecular Diagnostics in Healthcare
HIGH GROWTH AREAS OF MOLECULAR DIAGNOSTICS
HIGH-GROWTH REGIONAL MARKETS
2: Analysis: High-Growth Markets For Molecular Diagnostics
HIGH REVENUE GROWTH MOLECULAR TESTING AREAS IDENTIFIED
High Growth Categories in the Infectious Disease Molecular Diagnostics Market Market Size in 2016 and Forecast to 2021
High-Growth Regions for Infectious Disease Diagnostics Market (2016-2021)
High Growth Infectious Disease Market Area
High Growth Regions, NAT Blood Screening Market Market Size 2016 and Forecast to 2021
High Growth Cancer Market Area
High Growth Cancer Testing Areas, Market Size 2016 and Forecast 2021
Molecular Cancer Testing High Growth Regions
High Growth Cancer Testing Regional Markets
Other Molecular Testing High-Growth Areas, Market Size 2016 and Forecast 2021
High Growth Regional Markets for Other Testing
High-Growth Regional Markets for Other Molecular Diagnostics Testing
For more information about this report visit https://www.researchandmarkets.com/research/hjsvb7/global_molecular?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Molecular Diagnostics


SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Washington Post Publisher Will Lewis Steps Down After Layoffs
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Anta Sports Expands Global Footprint With Strategic Puma Stake
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



